跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 8,260 条关于
“AAE-C1INH”
全部
8,260
临床试验
7,256
药物
579
机构
25
资讯
400
去年
Pharvaris Advances Deucrictibant for HAE and AAE, Outlines 2025 Priorities
去年
European Commission Grants Orphan Designation to Pharvaris' Deucrictibant for Bradykinin-Mediated Angioedema
9天前
Pharvaris's Oral Deucrictibant XR Cuts HAE Attack Rate 83% in Phase III CHAPTER-3
去年
FDA Accepts Donidalorsen NDA for Hereditary Angioedema Prophylaxis
去年
Navenibart Shows Promise in Reducing Hereditary Angioedema Attacks in Phase 1b/2 Trial
去年
FDA Delays Sebetralstat Approval Decision for Hereditary Angioedema Treatment Due to Resource Constraints
3个月前
AI-Powered Retinal Scans May Unlock Early Detection of Heart and Brain Disease, Two Landmark Studies Show
去年
Donidalorsen Shows 62% Reduction in HAE Attacks When Patients Switch from Other Prophylactics in Phase 3 Study
2年前
KalVista Submits NDA to FDA for Oral Sebetralstat in Hereditary Angioedema
去年
KalVista to Present Sebetralstat Data at Major Medical Conferences as FDA Review Continues
第 1 页,共 40 页
上一页
下一页